ISRG - Intuitive Surgical, Inc.
| Previous Close | 513.64 |
| Open | 508.04 |
| Bid | 518.77 x 900 |
| Ask | 524.85 x 1400 |
| Day's Range | 507.11 - 524.04 |
| 52 Week Range | 359.75 - 581.12 |
| Volume | 644,204 |
| Avg. Volume | 768,975 |
| Market Cap | 59.217B |
| Beta (3Y Monthly) | 1.20 |
| PE Ratio (TTM) | 77.46 |
| EPS (TTM) | 6.69 |
| Earnings Date | Oct 17, 2018 - Oct 22, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 589.07 |
- Motley Fool•55 minutes ago
3 Healthcare Stocks That Have a Killer Advantage
They dominate their respective niche markets. And all three markets are growing rapidly.
- Zacks•22 hours ago
Intuitive Surgical (ISRG) Down 0.7% Since Last Earnings Report: Can It Rebound?
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Investor's Business Daily•4 days ago
When To Buy Growth Stocks: Some Leaders Can Still Run After Forming Late Stage Bases
While Intuitive Surgical showed why late-stage bases are an excellent topping signal, it also proves how some great companies can eventually lead again.
- Simply Wall St.•3 days ago
Why Intuitive Surgical Inc (NASDAQ:ISRG) Is An Attractive Investment To Consider
Intuitive Surgical Inc (NASDAQ:ISRG) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the Read More...
- Zacks•3 days ago
Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?
Is (ISRG) Outperforming Other Medical Stocks This Year?
- Zacks•4 days ago
Intuitive Surgical (ISRG) Dips More Than Broader Markets: What You Should Know
Intuitive Surgical (ISRG) closed at $498.64 in the latest trading session, marking a -0.95% move from the prior day.
- Zacks•4 days ago
GNC Holdings (GNC) Q3 Earnings Miss on Soft U.S. Retail
GNC Holdings (GNC) discourages with sluggish domestic retail comps. However, it delivers a strong performance in e-commerce business as well as at International segment.
- Zacks•4 days ago
Looking for a Growth Stock? Why It is Time to Focus on Intuitive Surgical (ISRG)
Intuitive Surgical (ISRG) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
Market Realist•4 days agoGauging Analysts’ Views on TransEnterix Stock
In November, of the five analysts covering TransEnterix (TRXC), three have given it “buy” or higher ratings, and two have given it “hold” ratings.
Market Realist•5 days agoUnderstanding TransEnterix’s Operational Performance
For 2018 and 2019, TransEnterix’s gross margins are expected to be 41.40% and 48.76%, respectively, compared to its gross margin of 5.4% in 2017. In comparison, the 2018 gross margins of its peers Intuitive Surgical (ISRG), Johnson & Johnson (JNJ), and Stryker (SYK) are expected to be 71.01%, 70.43%, and 66.29%, respectively. TransEnterix incurred general and administrative expenses of $3.69 million in the third quarter compared to $2.92 million in the third quarter of 2017 primarily due to higher personnel costs and outsourced services expenses.
Market Realist•5 days agoHow TransEnterix Has Been Performing in November
TransEnterix (TRXC) is a medical device company focused on digitizing the interface between surgeons and patients for the improvement of minimally invasive surgery. TransEnterix’s Senhance surgical system digitizes laparoscopic minimally invasive surgery and allows for robotic precision, haptic feedback, surgeon camera control, and improved ergonomics. TransEnterix generated total revenue of $5.42 million in the third quarter compared to $183,000 in the comparable period of 2017.
- Zacks•5 days ago
Phibro Animal (PAHC) Q1 Earnings Lag Estimates, Sales Up Y/Y
Within Animal Health business of Phirbo Animal (PAHC), reduced selling prices across certain countries partially offset its international volume growth.
- Zacks•5 days ago
OPKO Health (OPK) Incurs Loss in Q3, Lags Revenue Estimates
OPKO Health (OPK) gains from robust demand for its flagship RAYALDEE in Q3; adjusted gross margin remains pressed.
- Zacks•5 days ago
athenahealth (ATHN) Q3 Earnings Beat, Bookings Down Y/Y
athenahealth's (ATHN) Business and Services unit sees a strong Q3; 2018 guidance maintained.
- Zacks•5 days ago
Haemonetics (HAE) Earnings & Revenues Beat Estimates in Q2
Haemonetics' (HAE) year-over-year growth in Q2 is backed by benefits from complexity reduction and investments along with strength in market demand and success from early launches.
- Zacks•5 days ago
DexCom (DXCM) Beats Q3 Earnings Estimates, Raises '18 View
Solid contribution from the Sensor, Transmitter and Receiver segments drives DexCom's (DXCM) Q3 results.
- Zacks•6 days ago
Surmodics' (SRDX) Q4 Earnings and Revenues Beat Estimates
Surmodics (SRDX) sees solid segmental performance in fiscal Q4; gains from alliance with Abbott.
- Motley Fool•6 days ago
Better Buy: Intuitive Surgical (ISRG) vs. Align Technology (ALGN)
It all comes down to one thing: patents. Find out who that benefits.
- Zacks•9 days ago
DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss Estimates
DENTSPLY SIRONA (XRAY) witnesses dismal segmental performance in Q3; 2018 guidance lowered.
- Zacks•9 days ago
BioScrip (BIOS) Q3 Loss Wider Than Expected, Revenues Beat
A shift in BioScrip's (BIOS) strategy to focus on growing its core revenue mix plus contract changes with the UnitedHealthcare dent the company's revenue rise in Q3.
- Zacks•9 days ago
Wright Medical (WMGI) Reports Q3 Loss, Raises '18 Guidance
Growth in the upper and the lower extremity segments drives Wright Medical's (WMGI) Q3 results
- Zacks•9 days ago
Inogen (INGN) Q3 Earnings Beat, 2018 Revenue Guidance Up
Inogen (INGN) gains from solid direct-to-consumer revenues in Q3; 2018 view up.
- Zacks•9 days ago
Genomic Health (GHDX) Q3 Earnings and Revenues Top Estimates
We are encouraged by the year-over-year rise in Genomic Health's (GHDX) revenues in Q3, driven by solid performances in the United States and internationally.
- GlobeNewswire•9 days ago
Intuitive Announces New General Manager in Korea
Intuitive Surgical, Inc. (ISRG), has named Austin Kim as Vice President and General Manager in Korea, where he will direct business strategy and operations for the company. Intuitive pioneered the field of robotic-assisted, minimally invasive surgery with the creation of its da Vinci Surgical System. Now on its fourth-generation system, the Silicon Valley-based company has seen more than five million robotic-assisted surgical procedures performed worldwide, and more than 43,000 physicians worldwide trained on da Vinci systems.
- Zacks•10 days ago
Intuitive Surgical (ISRG) Dips More Than Broader Markets: What You Should Know
Intuitive Surgical (ISRG) closed at $540.02 in the latest trading session, marking a -1.04% move from the prior day.
